Category English

Study Finds Arthritis Drug Enbrel Overpatented, Overpriced in US

Initiative for Medicines, Access & Knowledge (I-MAK) released a new study yesterday showing that the rheumatoid arthritis drug Enbrel has been overpatented by drugmaker Amgen, which has filed a total of 57 patents on the drug in the United States. Together, these patents were said to delay market competition by 39 years, rather than the standard 20 years for one patent. The study found that this market exclusivity for Enbrel resulted in US$ 8 billion dollars in sales in 2017 alone.

WHO Director Tedros Gives Thoughts On Access To Medicines, Gene Editing, Ebola

World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) met with United Nations journalists today, in what he said would become a regular end-of-the-year meeting with the press. He gave an update on the ongoing Ebola outbreak and his views on the recent human gene editing by a Chinese researcher, and on the use of gene drive organisms to fight malaria. He also provided his views on access to affordable and safe medicines.

China Pulling The Cart To Propel Global IP Filings To New Heights, Trademarks Skyrocketing – WIPO

Global intellectual property filing numbers kept rising unabated in 2017, as China continued to pull the numbers upwards. The World Intellectual Property Indicators 2018, published today, also showed what the head of the World Intellectual Property Organization qualified as extraordinary growth in trademark applications. And he remarked on the increasing importance of intellectual property in the contemporary economy.

Conferences On Medicines Patent Information, Patent Office Cooperation, At WIPO This Week

The World Intellectual Property Organization patent law committee meeting this week will convene two half-day conferences, one on cooperation between patent offices, and the other on publicly accessible databases on patent information on medicines and vaccines. Other topics for discussion will be patents and health, confidentiality of communications between patent applicants and their advisors, quality of patents, and the research exception.

WIPO Copyright Committee Closing Chair’s Text Shows Way Forward On Broadcasting Treaty, Exceptions, Resale Right

The World Intellectual Property Organization Standing Committee on Copyright and Related Rights concluded its work in a weeklong meeting early today, a rare occurrence, after agreeing on ways forward for a draft treaty on broadcasting, limitations and exceptions for a range of groups such as libraries and educational institutions, and additional topics such as creation of a task force on artists' resale royalty rights, and upcoming regional meetings. The final chair's text below shows the details.

Interviews With National Publishing Industry Attendees At WIPO’s Copyright Committee

During this week's World Intellectual Property Organization copyright committee meeting, Intellectual Property Watch had the opportunity to meet observers from the international publishing sector who are following the committee's discussions closely. In Geneva at the invitation of the International Publishers Association (IPA), several publishers shared their thoughts about WIPO's work as well as their experience from their own markets. The interviews below represent a range of perspectives, from three different types of markets worldwide.

WIPO Draft Broadcasting Treaty: NGO Views On What To Keep, What To Change

The World Intellectual Property Organization draft treaty for the protection of broadcasting organisations was the focus not only of informal meetings among delegates this week, but also outside the negotiating room. On 27 November, Knowledge Ecology International (KEI) provided committee participants the impressions of five speakers keen on the topic, each with a different point of view underlining things they feel have to be improved to get to an effective treaty.

CBD Biennial Meeting Closes With Resolutions On Digital Sequence Data, Conflicts Of Interest, Global Benefit-Sharing

The biennial meeting of the Convention on Biological Diversity and its protocol on access and benefit-sharing closed yesterday with a list of adopted decisions. Among them was a decision to commission several studies on the impact of digital sequence data on the CBD for a recommendation at the next meeting in 2020. Delegates also agreed on a study to examine cases of genetic resources, and traditional knowledge associated with genetic resources, not yet covered by the protocol. Also adopted is the first decision on the management and prevention of conflicts of interest in expert groups.

Economically Sound And Fair Global Genetics Benefit-Sharing System Possible, Panellists Say

SHARM EL-SHEIKH, Egypt -- UN Convention on Biological Diversity members were trying this week to address questions that were left open when its protocol on access and benefit-sharing was adopted eight years ago. One of them is how to deal with genetic resources which are not yet covered by the protocol. A side event to the biennial conference of CBD members this week presented a solution, which they say could provide a more efficient, cost-effective and fairer system of access and benefit-sharing, based on inventions protected by intellectual property rights.

Fight Over .Amazon: ACTO Countries Cancel Meeting With ICANN CEO

The fight over delegating the .amazon top-level domain to Amazon LLC is not over. But the effort of the Internet Corporation for Assigned Names and Numbers (ICANN) to cut a deal between the regional Amazon Cooperation Treaty Organisation (ACTO) and online retailer Amazon has failed, according to ICANN CEO Göran Marby. [updated]